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Iranian J Parasitol: Vol.  5 , No. 4 , 20 10 , pp .   42 - 47     42                 Original  Article     Prevalence of  Cryptosporidium  Infection in Immunocompromised   Pa tients, In South - West of Iran, 2009 - 10     A Balouty Dehkordy 1 , *A Rafiei  1,2 , SM Alavi 2,  SM Latifi 3       1  Department of Myco - parasitology, Faculty of Medicine, Jundis hapur University of Medical Sciences,  Ahvaz, Iran   2  Infectious Diseases and Tropical Medicine Research Center, Faculty of Medicine, Jundishapur Univer - sity of Medical Sciences, Ahvaz, Iran   3  Statistic and Epidemiology Department, Faculty of Public Health,  Jundishapur University of Medical  Sciences, Ahvaz, Iran     (Received  10 May 2010 ;  accepted  11  Oct 2010 ) ’   Abstract   Background:  Cryptosporidium  is a protozoan parasite with worldwide distribution. The aim of  this study was to estimate the prevalence of  Cryptos poridium  infection by antigen detection in  faeces  among  immunocompromised  patients  referred  to  educational  hospitals  of  Ahvaz  City,  South - West of Iran, 2009 - 2010.    Methods :  Fecal  samples  from  176  immunocompromised  patients  were  collected  and  Cryptosporid i um  coproantigen test was performed using ELISA method (DRG kit, Germany). A  questionnaire was completed for each case and the results were analyzed using descriptive and  Chi - Square tests, by SPSS statistical software (15 th  version).   Results:  Our study indi cated 5.1%  Cryptosporidium  infection prevalence in the immunocompro - mised participated population. Furthermore, 4.2 %, 4%, 4.5 % and 9.1% infection rates were  identi fied in children suffered from hematopoietic malignancy, adult cancer patients, renal tran s - plant recipients, and HIV +  cases, respectively. There was not significant correlation between the  infection and age and gender ( P >0.05).  Infection was most frequent among HIV +  patients .   Conclusion : The present study confirmed the high prevalence of  Cryp tosporidium  antigen in fe - cal samples of immunocompromised patients in the region. As no chemotherapeutic agents have  yet proven, especially in immunosuppressed patients, therefore our results highlight the impor - tance of preventive intervention in these g roups.   Keywords:  Cryptosporidium,  Coproantigen, Immunocompromised patients, ELISA, human, Iran       Introduction               Iranian Society of Parasito l ogy   http:// isp.tums.ac.ir     Iranian J Parasitol     Open access Journal at   http:// ijpa.tums.ac.ir     Tehran University of Med i cal  Sciences Public a tion   http:// tums.ac.ir         * Corresponding author:   Fax: 0611 - 3331544 ,     Email: rafi eiabdollah@ yahoo.com    Balouty Dehkordy  et al   :  Prevalence of Cryptosporidium Infection …     43   Introduction     ryptosporidiosis is caused by   Crypto - sporid ium   strains,  a  parasite  classi - fied as emerging pathogens. The or - ganism  in fects  th e  gastroin testinal  epithe - lium to pro duce a diar rhea that is self - limited  in  immuno compe tent  persons,  but  poten - tially life threat ing in im munocompromised  per sons  (1).  Furthermore,   Cryptosporidium   stated an organism with low infective dose  and resi s tant to conven tional water disinfec - tants (2). In addition, no definitive treatment  and proven protocol has been achieved for  crypto sporidiosis (3). There fore, prevention  seems  to  be  the  main  effective  disease  protec tion,  especially  among  immuno - comp ro mised individuals.   Immunocompromised patients such as HIV +   patients  with  malignant  disease, post - trans - plant patients and children under 5 years old,  are at high risk to develop diarrheal disease  caused by  Cryptosporidium .   Because  of  the  lack  of  updated   data,  this  study  was  conducted  to  estimate  Crypto - sporidium   prevalence  in  immunocompro - mised patients, in south - west of Iran.        Materials and Methods     This  cross  sectional  study  was  performed  among  immunocompromised      patients  re - ferred to educational ho spitals of Ahvaz Jun - dishapur  University  of  Medical  Sciences  dur ing 2009 - 2010.   Overall, 176 patients including 48 children  with lymphohematopoietic malignancies and  50 adults with malignancies, admitted to He - matology Department of Shafa Hospital and  unde rwent  chemotherapy  were  included  in  the study. Fifty - five renal transplant patients  and  33  confirmed  HIV +   patients  were  also  participated.  The patients  were  interviewed  and  a  questionnaire  was  completed  for  demo graphical, hygienic, and environmental  life  style.  The  study  was  approved  by  the  Ethical  Committee  of  the  Jundishapur  Univer sity of Medical Sciences, Ahvaz, Iran.   A total 176 stool samples were collected and  stored at  - 20°C without any preservative un - til  used.  The  ELISA,  DRG  diagnostic  kits  (EIA - 3 467, Germany) was used for  Crypto - sporidium   antigen  detection  in  stool  sam - ples.    The  samples  were defrosted and en - zyme  immunoassay  was  performed  as  de - scribed  by  the  manufacturer.  The  results  were  carried  out  spectrophotometrically  at  450 nm using Dynate ch ELISA reader. Ac - cording to manufacturer guideline, the speci - men was considered positive if optical den - sity was more than 0.15.   Statistical analysis was conducted with Chi - square and Fisher exact tests. The data were  analyzed using SPSS statistical so ftware ver - sion 15 th .     Results     Among  176  immunocompromised  patients,  9  (5.1%)  cases  were  positive  for   Crypto - sporidium  antigen. Of these, 2 and 7 cases  were among 1 - 15 and 16 - 75 year old group,  re spectively.  No  significant  correlation  be - tween  Cryptospor idium  infection frequency,  age, and gender was obtained (Table 1, 2).  Fre quency of  Cryptosporidium  infection was  9.1%,  4%,  4.2%  and  4.5  %  among  HIV + ,  adults  with  malignancies,  children  suffered  from  lymphohematopoietic  malignancy  and  re nal transplant pat ients, respectively (Table  3).   The  freeze/thaw  associated  instability  of  Cryptosporidium   antigen  in  nine  positive  sam ples was analyzed. Only two stool sam - ples were positive after second freeze - thaw  cy cle.   C  Iranian J Parasitol: Vol.  5 , No. 4 , 20 10 , pp .   42 - 47     44   Table 1 : Frequency of  Cryptosporidium  infection  in immunocompromised patients according  to gender     Total   Negative   Positive   %   No.   %   No.   %   No.   ELISA           Gender   100   120   94.2   113   5.8   7   Male   100   56   96.4   54   3.6   2   Female     Table 2 : Frequency of  Cryptosporidium  infection in immunocompromised patients accor ding  to age     Positive   Negative   Total      ELISA     Age  (year)   No.   %   No.   %   No.   %   1 - 15   2   4.2   46   95.8   48   100   16 - 76   7   5.5   121   94.5   128   100       Table 3 : Frequency of  Cryptosporidium  infection according to type of immunosuppressant ill - ness     Negati ve   Positive   Total   ELISA     Illness   No.   %   No.   %   No.   %   Children   Malignancy   46   95.8   2   4.2   48   100   Adult   Malignancy   48   96   2   4   50   100   Kidney Recipi - ents   43   95.5   2   4.5   45   100   HIV+   30   90.9   3   9.1     33   100   Total   167   94.9   9   5.1   176   100      Balouty Dehkordy  et al   :  Prevalence of Cryptosporidium Infection …     45   Discussion       Cryptosporidiosis is reco gnized as an impor - tant gastroenteritis disorder of immunocom - promised patients. In such cases, it may lead  to  high  morbidity  and  mortality  (4).  The  prevalence  of  Cryptosporidium   antigen  in  stool  examination  by  ELISA  in  immunocom promised  patients  was  5.1% .  Similar studies in Iran indicated the preva - lence rates of 1.4%, 11.5%, 22%, and 26.7%  within  immunocompromised  patients  (5 - 8).   Higher  prevalence  rates  (17 - 61.1%)  have  been  reported  in  India  and  Turkey,  among  im munocompromised patients with diarrhea  (9 - 12). There are discrepancies in prevalence  rates  of  Cryptosporidium   sp.  in  Iran  and  other  countries  (13).  Probably  different  situa tion  of  hygienic  life  styles  and  living  envi ronmental are responsible for these vari - able levels of infection.    There was o nly one infected case with diar - rhea in our study. As this parasite has been  rec ognized  to  cause  sever  life - threatening  dis order, even in non - diarrheic immunocom - promised  patients,  therefore  the  reliable  tech nique  for  demonstration  of  oocysts  in  stool e xamination of such patients is neces - sary.   In  this  study,  infection  was  most  frequent  among HIV +  cases. Higher rate of infection  in HIV +  patients have been reported ranged  from 8.7% to 26.7% in Iran and 0% to 100%  in  other  countries  (4,8,14,15).  This  findi ng  may be because HIV +  patients suffered from  immunological  disturbances  predominantly  from cellular immunoresponce of T helper 1  cell.    On  the  other  hand,  in  our  study  the  most  cases  had  addiction  and  were  in  low  so cioeconomic  level,  besides,  they  did  no t  use safe and hygienic drinking water.    In the current study,  Cryptosporidium  preva - lence was 4.5% in renal transplant patients.   Different rates of infection from 2.4%, 4.5%  and 11.5% have been reported from Iranian  communities  (6,  16,  17).    In  some  othe r  coun tries, 18.8% and 20% rates of infection  have  been  indicated  (18,  19).  Renal  trans - plant patients in our study were under cyc - losporine A treatment.  Cyclosporine A as an  immunosuppressive treatment also acts as an  antiparasite  agent,  therefore  it  se ems  this  situa tion could result to reduce infection rate  of  Cryptosporidium   (20).    Furthermore,  in  our  study  transplant  patients  used  hygienic  wa ter as advised by health centers. Current  study  indicated  Cryptosporidium   infection  rate  of  4.2%  and  4%  in  ch ildren  with  hemato poeitic and adult cancer patients, re - spectively.  Higher  rate  of  infection  have  been reported by others (7, 21 - 23).   Analysis of  Cryptosporidium  antigen viabil - ity in feces suggests the possibility that some  samples may become negative in  ELISA af - ter  second  freeze/thaw  process.  Similar  re - sults  have  been  reported  for  other  parasite  in fections (24). These data suggest that fresh  sample  should  be  used;  if  not  possible,  a  care ful  of  sample  handling  must  be  per - formed.    The present study co nfirmed the high preva - lence  of   Cryptosporidium   antigen  in  fecal  sam ples of immunocompromised patients in  the  region.  As  no  chemotherapeutic  agents  have  yet proven, especially in immunosup - pressed patients, therefore our results high - light the importance  of preventive interven - tion in these groups.   ELISA showed high sensitivity and specific - ity with reliable results for  Cryptosporidium   antigen  detection  in  stool  (25).  In  addition  cryptosporial  antigens  may  be  present  in  stool  without  existence  the  whole  oo cysts  (26),  therefore  its  application  in  routine  diagno sis and even large - scale epidemiologi - cal surveys is recommended.       Iranian J Parasitol: Vol.  5 , No. 4 , 20 10 , pp .   42 - 47     46   Acknowledgements     We thank the hospital staff and patients, who  participated in the survey  undertaken.   We  acknowledge the Jundisha pur University of  Medical  Sciences,  Ahvaz,  Iran  for  their  finan cial  support.  The  authors  declare  that  they have no conflicts of interest.      References   1 .   Gerald  DS,  Larry  SR.  Foundations  of  para sitology.  7th  ed.  Mc  Graw  Hill   Compa nies; 2006:141 - 42.   2 .   Havelar  A, Boonyakarnkul T, Cunliffe D,  et al. Guidelines for drink ing water qulity,  water  born  patho gens.   Geneva:WHO;  2003.   3 .   Abubakar I, Aliyu SH, Arumugam C, Us - man NK, Hunter PR. Treatment of crypto - sporidiosis in immunocompro mised indi - viduals: systemic rev iew and meta analy - sis. Br J Clin Phama col. 2007;63(4):387 - 93.   4 .   Paul RH, Gordon N. Epidemiology and  clinical features of  Cryptosporid ium  infec - tion in immunocompromise patients.   Clin  Mic Reviews. 2002;15(1):145 - 54.   5 .   Nahrevanian  H,  Assmar  M.  Crypto - sporidi osis  in  immunocompromised  pa - tients in the Islamic Republic of Iran.   J Mi - crobiol Immunol Infect .  2008;41:74 - 77.   6 .   Hazrati  Tappeh  Kh,  Gharavi  MJ,  Mkhdoumi K, Rahbar M, Taghi zadeh H.  Prevalence of  Cryptosporid ium  sp .   infec - tion in renal transplant and heamo dialysis  Ira nian  patients.  Iranian  J  Publ  Health .  2006; 35(3):54 - 57.   7 .   Berenji  F,  Zabolinejad  N,  Kianifar  HR,  Badeii  Z,  Banihashem  A,  Hirad far  S.  Crypto sporidium  infection in pe diatric pa - tients  with  lymphohemato poietic  malignan cies. Iran J Ped. 2007;  17(3):247 - 51.   8 .   Taherkhani  H,  Fallah  M,  Jadidian  K,  Vaziri S. A study on the  prevalence of   Cryptosporidium  in HIV positive patients .  J Res Health Sci. 2007;7(2):20 - 24.   9 .   Ballal M, Prabhu T, Chadran A, Shiva - nanda  P.  Cryptosporidium  and  Isospora  belli   diarrhea   in  immunocom promised  hosts . .  Indiana  J  Cancer.  1999;Mar;  36(1):38 - 42.    10 .   Ramakrishnun K, S Rajaiah Shen barathai,  Uma A. Prevalence of intesti nal parasitic  in festation  in  HIV/AIDS  patients  with  diar rhea in Madurai City, South India. Jpn  J In fect  Di . 20 07; 60(4):209 - 10.   11 .   Tany M. Prevalence of  Cryptosporid ium   spp   in patients with neoplasia and diar - rhea.   Sand J Infect Dis. 1995; 27(1):69 - 70.   12 .   Arikan S, Ergn,Aky Y, Glp A. Crypto - sporidiosis  in  immunocompro mised  pa - tients  in  a  Turkish  university  hospitals.   Acta  Mi crobial  Immuno  Hung.  1999;  46(1):33 - 40.   13 .   Mirzaei M. Prevalence of  Crypto sporid - ium sp  infection in diarrheic hu mans in  Iran.   Kor J Parasitol. 2007; 45(2):133 - 37.   14 .   Meamar AR, Rezaian M, Mohraz M, Za - habiun F, Hadighi R, Kia EB. A compara - tive analys is of intestinal para sitic infection  between HIV + /AIDS patients and non in - fected  individuals .  Indian  J  Parasitol .   2007; 2(1):1 - 6.   15 .   Nahrvanian H, Assmar M. A case re port  of cryptosporidiosis and isosporidi asis in  AIDS patients in Iran. J Trop Med Parasi - tol. 2006; 29:33 - 6.     16 .   Nateghi Rostami M, Keshavarz H, Eskan - dari  E,  Kia  EB,  Rezaeian  M.  In testinal  para sitic  infections  in  renal  transplant  recipi ents.  Iranian  J  Parasitol.  2007;  2(3):16 - 23.   17 .   Valar C, Keitel E, Dal Pra Rl, Gnatta D,  Santos  AF.  Parasitic  infection  in  renal  trans plant  recipients .  Transplant  Proc.  2007; 39:460 - 2.   18 .   Ok UZ, Cirit M, Uner A, Akcicek F, Ba - sic A, Ozcel MA. Cryptosporidiosis and Balouty Dehkordy  et al   :  Prevalence of Cryptosporidium Infection …     47   blastocystosis in renal transplant recipients .  Nephron. 1997; 75:171 - 74.   19 .   Minz M, Udgiri NK, Heer MK, Ka shyap  R. Cryptosporidiosis in live related renal  transplant  recipients:  A  single  center  experi ence .  Transplant. 2004; 77:1916 - 17.   20 .   Chappell LH, Wastling JM. Cyclosporin  A: antiparasite drug modulator of the host  parasite relationship and immunosuppres - sant . Parasitol.1992; 105:25 - 40.   21 .   Hassan SI, Sabry H, Amer NM, Shalaby  M A, Mohamed NA, Gaballah H. Inci - dence of cryptosporidiosis in immunodefi - cient cancer patients in Egypt. J Egypt Soc  Parasitol. 2002; 32(1):33 - 46.   22 .   Rivera WL, Yason J A, Riveran PT. Sero - lo gical  detection  of  cryptosporidiosis  among Filipino cancer patients. Parasitol  Res. 2005; 98(1):75 - 76.   23 .   Baqai R, Anwar S, Kazmi SU.  Detection  of  Cryptosporidium  in immunosuppressed  patients .  J Ayub Col Abbottabad. 2005;  17(3):38 - 40.   24 .   Barbieri M, Server MA, P irez MI, Bat - tiston J, Nietto A. Use of specific antibody  and circulating antigen serum levels in the  hydatid  immunodiagnosis  of  asympto - matic  population .  Inter  J  Parasitol . 1994;  24(7):937 - 42.   25 .   Jayalakshmi J, Appalaraju B, Mahadevan  K.  Evaluation  of  an  enzy me - linked  immuno assay  for  detection  of  Cryptosporid ium   antigen  in  fecal  speci - mens of HIV/AIDS patients. Indian J Pat  Mi crob; 2008;51(1):137 - 38.   26 .   Ungar BL. Enzyme - linked immunoas say  for detection of  Cryptosporid ium   antigens  in  fecal  speci mens.  J  Clin   Microbiol.  1990; 28:2491 - 5.        